000766.SZ
通化金马
SZSE · Healthcare · C 制造业 · CN
CNY 15.68
−1.07%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.2B | 1.2B | 1.3B | 1.5B | 1.5B |
| Cost of Revenue | 316.5M | 326.0M | 331.6M | 379.1M | 353.2M |
| Gross Profit | 854.2M | 843.9M | 991.0M | 1.1B | 1.1B |
| Operating Expenses | |||||
| R&D Expense | 44.3M | 39.8M | 50.3M | 45.8M | 64.9M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 116.3M | 115.2M | 117.3M | 112.9M | 108.3M |
| Selling & Marketing Expense | 569.9M | 561.9M | 671.9M | 792.1M | 815.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 827.3M | 813.2M | 929.4M | 1.0B | 1.1B |
| Cost and Expenses | 1.1B | 1.1B | 1.3B | 1.4B | 1.4B |
| Operating Income (EBIT) | 38.9M | 43.4M | 67.4M | 51.7M | 51.4M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 38.3M | 42.7M | 67.1M | 54.9M | 50.2M |
| Income Tax Expense | 6.5M | 8.5M | 11.1M | 11.6M | 21.0M |
| Bottom Line | |||||
| Net Income | 31.8M | 34.3M | 56.4M | 43.9M | 30.2M |
| Earnings from Cont. Ops | 31.8M | 34.2M | 56.0M | 43.2M | 29.2M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 31.8M | 34.3M | 56.4M | 43.9M | 30.2M |
| Per Share | |||||
| Basic EPS | CN¥0.04 | CN¥0.04 | CN¥0.06 | CN¥0.05 | CN¥0.03 |
| Diluted EPS | CN¥0.04 | CN¥0.04 | CN¥0.06 | CN¥0.05 | CN¥0.03 |
| Revenue Per Share | CN¥1.21 | CN¥1.36 | CN¥1.41 | CN¥1.68 | CN¥1.46 |
| Shares | |||||
| Basic Shares Outstanding | 971.2M | 857.2M | 940.6M | 878.7M | 1.0B |
| Diluted Shares Outstanding | 971.2M | 857.2M | 940.6M | 878.7M | 1.0B |
| Profitability Metrics | |||||
| EBITDA | — | 105.2M | 132.5M | 126.7M | 123.2M |
| D&A | — | 61.8M | 65.0M | 75.0M | 71.8M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026